Clinical Trial Update: SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 clinical trial evaluating SGN-00101 for cervical intraepithelial neoplasia, a precancerous cervical condition. The current trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• SGN-00101

Snippet

Sponsor: Dana-Farber/Brigham and Women's Cancer Center | Conditions: Precancerous Condition | Phase 2 | Status: UNKNOWN